Quick Search:       Advanced Search
Low expression of miR-145 in tumor cells from renal cell carcinoma patients and its clinical significance
Received:January 19, 2020  Revised:March 13, 2020  Click here to download the full text
Citation of this paper:ZANG Yan,TU Xiao-hua,LI Jin-qi,ZHU Li-shuang,GUO Fei,LU Min,QIAN Bao-hua.Low expression of miR-145 in tumor cells from renal cell carcinoma patients and its clinical significance[J].Chinese Journal of Clinical Medicine,2020,27(3):418-421
Hits: 1778
Download times: 693
Author NameAffiliationE-mail
ZANG Yan Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China  
TU Xiao-hua Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China  
LI Jin-qi Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China  
ZHU Li-shuang Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China  
GUO Fei Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China  
LU Min Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China  
QIAN Bao-hua Department of Blood Transfusion, Changhai Hospital, Navy Medicical University, Shanghai 200433, China qianbh1963@163.com 
Abstract:Objective: To identify the micro-RNAs related to the regulation of CD40 signaling, and explore their roles in regulating the CD40 signaling in renal cell carcinoma, which may provide new and effective potential targets for the diagnosis and treatment of renal cell carcinoma in the future.Methods: The micro-RNA expression profiles of renal cell carcinoma and adjacent control cells were analyzed by gene chip. Bioinformatics predicted the micro-RNA that may regulate CD40, and its expression was verified by RT-PCR. Micro-RNA inhibitors and mimics were transfected in vitro to study their effects on the expression of CD40 and CD40L, and their effects on the secretion of cytokines and cell proliferation of renal cell carcinoma cells.Results: The expression of miR-145 was significantly reduced in the renal cell carcinoma group(P<0.01). After transfection with miR-145 inhibitor, CD40 expression was significantly increased in renal cell carcinoma cells, and there was no statistical difference in CD40L expression. After the transfection of miR-145 mimics, CD40 expression was significantly reduced in renal cell carcinoma cells, and there was no statistical difference in CD40L expression. After functionally elevating the expression of miR-145, the expression of tumor necrosis factor-α(TNF-α) and interferon-γ(IFN-γ) decreased significantly, and tumor cell proliferation slowed. After functionally decreasing the expression of miR-145, the expression of TNF-α and IFN-γ increased significantly, and tumor cell proliferation accelerated(P<0.01). After antagonizing the expression of CD40 and elevating the expression of miR-145, TNF-α, and IFN-γ were down regulated, but there was no statistical difference.Conclusions: miR-145 is significantly reduced in renal cell carcinoma cells, and by regulating the expression of CD40, it further regulates cytokine secretion and cell proliferation and promotes the occurrence and development of tumors.
keywords:miR-145  renal cell carcinoma  CD40  cytokines  cell proliferation
HTML  View Full Text  View/Add Comment  Download reader